Research primarily focuses on its role in managing diabetes and aiding weight loss
For individuals with obesity however, exercise capacity can be limited by comorbidites associated with excess weight
feel like i got my life back honestly James W., 41, Winnipeg MB Weeks 13-24 Summary: Peak Results Period Weight loss: 15-19 pounds this period (34-38 pounds total, ~17% of starting weight) Weekly loss rate: Averages 1.25-1.6 pounds weekly (slowing from early weeks but still excellent) Side effects: Minimal for most people
Liraglutide (Saxenda and Victoza) and dulaglutide are GLP-1 receptor agonists that have the same mechanism of action as semaglutide
Phase 2 (2023 published in New England Journal of Medicine) A landmark 48-week randomized controlled trial enrolled 338 adults with obesity (no diabetes)
The Distinction Between Branded and Compounded Tirzepatide When discussing FDA approval, it is vital to distinguish between branded medications and compounded versions